CTOs on the Move

Creative Circle

www.us-circle.com

 
Creative Circle is a Los Angeles, CA-based company in the Business Services sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.us-circle.com
  • 5750 Wilshire Blvd Ste 610
    Los Angeles, CA USA 90036
  • Phone: 323.930.2333

Executives

Name Title Contact Details

Similar Companies

City of Oak Park

The City of Oak Park is a diverse and vibrant community that prides itself on being a family-oriented city. The City spans 5.5 square miles and is home to over 30,000 citizens. Oak Park has wonderful resources to draw from, including our 10 public pa...

COMPUTERWORKS OF CALIFORNIA

COMPUTERWORKS OF CALIFORNIA is a Inglewood, CA-based company in the Business Services sector.

Korey Homes

Korey Homes is a Forest Hill, MD-based company in the Business Services sector.

Andrews Architects

Andrews Architects is a Portland, OR-based company in the Business Services sector.

Apellis Pharmaceuticals

Apellis Pharmaceuticals is a global biopharmaceutical company based in Waltham, Massachusetts. The company is focused on developing innovative therapies that target the complement system, a crucial part of the immune system. Apellis aims to create life-changing treatments for various debilitating diseases through its commitment to scientific research and patient care. The company has a diverse pipeline of products, including EMPAVELI, which is approved for treating paroxysmal nocturnal hemoglobinuria and is being investigated for other conditions. SYFOVRE is in development for geographic atrophy, along with a combination therapy involving APL-APL-3007. Apellis is also exploring RNA therapies and gene-edited treatments for multiple therapeutic areas. With a global presence in countries such as the US, Canada, and several European nations, Apellis serves patients and healthcare providers affected by diseases related to the complement system. The company reported approximately $709 million in U.S. net product revenues for the full year 2024, reflecting its strong market position and commitment to advancing its therapeutic offerings.